Spectrum of Behavior.-The clinical behavior of well-differentiated-papillary and follicular-
thyroid carcinoma has become increasingly clearer in recent years. Almost all physicians …

Background: Survival studies in differentiated thyroid carcinoma (DTC) may be biased
because they have been performed in heterogeneous populations. In addition, specific …

Background Thyroid nodules are a common clinical problem, and differentiated thyroid
cancer is becoming increasingly prevalent. Methods Six scientific Italian societies entitled to …

Thyroid cancer is uncommon with an estimated lifetime risk of 0.8% for women and 0.3% for
men. The incidence appears to be increasing by 4% per year and is currently the eighth …

Advanced differentiated thyroid cancer (DTC), defined by clinical characteristics including
gross extrathyroidal invasion, distant metastases, radioiodine (RAI) resistance, and avidity …

Background: Poorly differentiated thyroid cancer (PDTC) accounts for only 1–15% of all
thyroid cancers. Our objective is to report outcomes in a large series of patients with PDTC …

Controversy continues regarding the optimal management of patients with differentiated
thyroid cancer because no prospective randomized studies evaluating the merits of (1) …

Thyroid cancer incidence is increasing, although mortality is stable. The major cause of the
increased incidence is detection of subclinical disease–overdiagnosis. Patients are still …

Papillary and follicular thyroid cancer, together referred to as differentiated thyroid cancer
(DTC), is usually curable when discovered at an early stage. Its management, however, is …

This ESMO Clinical Practice Guideline provides updated state-of-the-art recommendations
on management of thyroid cancer (diagnosis, treatment and follow-up), compiled by a …